Investors

TwinStrand’s transformational improvements in DNA sequencing accuracy deliver 10,000x greater sensitivity, making it a crucial tool for genomic research and medicine. Founded and based in Seattle’s thriving Biotechnology community, we are committed to applying our Duplex Sequencing™ technology across disciplines to improve human health and accelerate scientific discovery. Our approach is multifaceted and encompasses internal development projects, external collaborations and empowering of partner organizations. Our operation is strongly rooted in academic principles of responsible citizenship within the broader scientific community, yet executed with the nimbleness of a startup, such that research can be rapidly translated into products that benefit people.